STAAR Surgical Co Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale
STAAR Surgical Co (STAA) reported Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale of $32.52 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities · last filed 2026-08-12
- STAAR Surgical Co proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-07-03 was $27.06M, a 2.44% increase year-over-year.
- STAAR Surgical Co proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-04-03 was $5.46M, a 89.33% decline year-over-year.
- STAAR Surgical Co proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2026-01-02 was $31.16M, a 547.57% increase year-over-year.
- STAAR Surgical Co proceeds from maturities, prepayments and calls of debt securities, available-for-sale for the quarter ending 2025-09-26 was $15.42M, a 29.23% increase year-over-year.
- STAAR Surgical Co proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2026 was $124.14M, a 188.02% increase from fiscal 2024.
- STAAR Surgical Co proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2024 was $43.10M, a 69.97% decline from fiscal 2023.
- STAAR Surgical Co proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2023 was $143.55M, a 738.43% increase from fiscal 2022.
- STAAR Surgical Co proceeds from maturities, prepayments and calls of debt securities, available-for-sale for fiscal 2022 was $17.12M.
| Period end | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 3 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 6 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 9 month | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale 12 month |
|---|---|---|---|---|
| 2026-07-03 | $27.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $32.52M 10-Q · filed 2026-08-12 | $63.68M derived: sum of 3 quarters · filed 2026-08-12 | $79.10M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-04-03 | $5.46M 10-Q · filed 2026-05-13 | $36.62M derived: sum of 2 quarters · filed 2026-05-13 | $52.04M derived: sum of 3 quarters · filed 2026-05-13 | $78.46M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-01-02 | $31.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $46.59M derived: sum of 2 quarters · filed 2026-03-03 | $73.00M derived: sum of 3 quarters · filed 2026-08-12 | $124.14M 10-K · filed 2026-03-03 |
| 2025-09-26 | $15.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $41.84M derived: sum of 2 quarters · filed 2026-08-12 | $92.98M 10-Q · filed 2025-11-05 | $97.80M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-27 | $26.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $77.56M 10-Q · filed 2026-08-12 | $82.37M derived: sum of 3 quarters · filed 2026-08-12 | $94.31M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-28 | $51.15M 10-Q · filed 2026-05-13 | $55.96M derived: sum of 2 quarters · filed 2026-05-13 | $67.89M derived: sum of 3 quarters · filed 2026-05-13 | $73.71M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-27 | $4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $16.75M derived: sum of 2 quarters · filed 2026-03-03 | $22.56M derived: sum of 3 quarters · filed 2026-03-03 | $43.10M 10-K · filed 2026-03-03 |
| 2024-09-27 | $11.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $17.75M derived: sum of 2 quarters · filed 2025-11-05 | $38.29M 10-Q · filed 2025-11-05 | |
| 2024-06-28 | $5.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $26.36M 10-Q · filed 2025-08-06 | ||
| 2024-03-29 | $20.54M 10-Q · filed 2025-05-07 | |||
| 2023-12-29 | $143.55M 10-K · filed 2026-03-03 | |||
| 2022-12-30 | $17.12M 10-K · filed 2025-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |